Elisabeth Dianne Riviello, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sepsis | 6 | 2021 | 2593 | 1.070 |
Why?
|
Rwanda | 8 | 2021 | 703 | 0.990 |
Why?
|
Critical Care | 11 | 2023 | 2647 | 0.990 |
Why?
|
Hospital Mortality | 8 | 2021 | 5317 | 0.820 |
Why?
|
Health Resources | 6 | 2019 | 911 | 0.790 |
Why?
|
Oxygen Inhalation Therapy | 3 | 2020 | 367 | 0.740 |
Why?
|
Health Care Rationing | 2 | 2022 | 437 | 0.680 |
Why?
|
Oxygen | 6 | 2024 | 4189 | 0.640 |
Why?
|
Oximetry | 3 | 2024 | 471 | 0.640 |
Why?
|
Standard of Care | 1 | 2022 | 564 | 0.620 |
Why?
|
Hyperoxia | 1 | 2019 | 262 | 0.590 |
Why?
|
Intensive Care Units | 9 | 2021 | 3679 | 0.570 |
Why?
|
Drug Resistance, Microbial | 1 | 2019 | 862 | 0.550 |
Why?
|
Developing Countries | 8 | 2022 | 2815 | 0.530 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 567 | 0.500 |
Why?
|
Respiration, Artificial | 6 | 2023 | 2569 | 0.500 |
Why?
|
Positive-Pressure Respiration | 2 | 2023 | 633 | 0.470 |
Why?
|
Residence Characteristics | 1 | 2022 | 2050 | 0.410 |
Why?
|
Bacterial Infections | 1 | 2019 | 1401 | 0.380 |
Why?
|
Cross Infection | 1 | 2019 | 1416 | 0.360 |
Why?
|
Life | 1 | 2008 | 13 | 0.330 |
Why?
|
Blood Transfusion | 1 | 2015 | 1301 | 0.320 |
Why?
|
Mining | 1 | 2007 | 88 | 0.300 |
Why?
|
Capacity Building | 2 | 2020 | 248 | 0.290 |
Why?
|
Kidney Tubules | 1 | 2009 | 488 | 0.280 |
Why?
|
Immunologic Factors | 1 | 2015 | 1580 | 0.270 |
Why?
|
Attitude to Death | 1 | 2008 | 382 | 0.260 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2016 | 1354 | 0.250 |
Why?
|
Health Priorities | 2 | 2022 | 380 | 0.240 |
Why?
|
Kenya | 3 | 2023 | 685 | 0.240 |
Why?
|
Gadolinium | 1 | 2009 | 952 | 0.230 |
Why?
|
Biomedical Research | 4 | 2019 | 3309 | 0.230 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.230 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2400 | 0.210 |
Why?
|
Critical Illness | 4 | 2019 | 2670 | 0.200 |
Why?
|
Respiratory Insufficiency | 2 | 2020 | 1199 | 0.200 |
Why?
|
Decision Making | 1 | 2015 | 3887 | 0.190 |
Why?
|
Occupational Health | 1 | 2007 | 809 | 0.190 |
Why?
|
Anti-Bacterial Agents | 2 | 2019 | 7181 | 0.190 |
Why?
|
Berlin | 2 | 2017 | 23 | 0.190 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7659 | 0.180 |
Why?
|
Lung | 4 | 2021 | 9856 | 0.180 |
Why?
|
Ventilators, Mechanical | 1 | 2022 | 292 | 0.170 |
Why?
|
Registries | 1 | 2015 | 8089 | 0.170 |
Why?
|
Delirium | 2 | 2021 | 1609 | 0.170 |
Why?
|
Acute Kidney Injury | 2 | 2009 | 1972 | 0.170 |
Why?
|
Humans | 41 | 2024 | 744343 | 0.170 |
Why?
|
Family Conflict | 1 | 2019 | 95 | 0.170 |
Why?
|
Models, Biological | 1 | 2015 | 9583 | 0.160 |
Why?
|
Blood Gas Analysis | 1 | 2019 | 383 | 0.160 |
Why?
|
Enterobacteriaceae | 1 | 2019 | 169 | 0.160 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 213 | 0.160 |
Why?
|
Gram-Negative Bacteria | 1 | 2019 | 270 | 0.150 |
Why?
|
Vasoconstrictor Agents | 1 | 2021 | 642 | 0.150 |
Why?
|
beta-Lactamases | 1 | 2019 | 306 | 0.150 |
Why?
|
Hospitals, University | 1 | 2019 | 571 | 0.150 |
Why?
|
Sputum | 1 | 2019 | 476 | 0.150 |
Why?
|
Hospitals | 2 | 2021 | 3952 | 0.150 |
Why?
|
Fluid Therapy | 1 | 2021 | 593 | 0.150 |
Why?
|
Evidence-Based Practice | 1 | 2021 | 500 | 0.140 |
Why?
|
Tuberculosis, Miliary | 1 | 2016 | 13 | 0.140 |
Why?
|
Vulnerable Populations | 1 | 2022 | 687 | 0.140 |
Why?
|
Meningitis, Cryptococcal | 1 | 2016 | 63 | 0.130 |
Why?
|
Contrast Media | 1 | 2009 | 5300 | 0.130 |
Why?
|
Physician-Patient Relations | 1 | 2008 | 3229 | 0.130 |
Why?
|
Adult | 13 | 2023 | 214055 | 0.130 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2009 | 2208 | 0.120 |
Why?
|
Hospitals, Public | 1 | 2016 | 207 | 0.120 |
Why?
|
Shock, Septic | 1 | 2021 | 775 | 0.120 |
Why?
|
Education, Medical | 2 | 2020 | 1721 | 0.120 |
Why?
|
Middle Aged | 11 | 2022 | 213383 | 0.120 |
Why?
|
Career Choice | 1 | 2020 | 744 | 0.120 |
Why?
|
Quality Improvement | 2 | 2019 | 3749 | 0.120 |
Why?
|
Male | 14 | 2023 | 350118 | 0.110 |
Why?
|
ROC Curve | 1 | 2021 | 3527 | 0.110 |
Why?
|
Female | 14 | 2023 | 380194 | 0.110 |
Why?
|
Information Dissemination | 1 | 2021 | 1099 | 0.110 |
Why?
|
Botswana | 2 | 2023 | 1040 | 0.110 |
Why?
|
Hospitalization | 2 | 2022 | 10262 | 0.100 |
Why?
|
Terminal Care | 1 | 2023 | 1694 | 0.100 |
Why?
|
Mortality | 2 | 2021 | 2864 | 0.100 |
Why?
|
Demography | 1 | 2016 | 1656 | 0.100 |
Why?
|
Disabled Persons | 1 | 2021 | 1212 | 0.100 |
Why?
|
Reproducibility of Results | 3 | 2024 | 19905 | 0.100 |
Why?
|
Quality of Health Care | 3 | 2018 | 4371 | 0.100 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 7913 | 0.090 |
Why?
|
Income | 2 | 2022 | 1913 | 0.090 |
Why?
|
Probability | 1 | 2016 | 2505 | 0.090 |
Why?
|
Zambia | 2 | 2021 | 261 | 0.090 |
Why?
|
Point-of-Care Systems | 1 | 2018 | 1177 | 0.090 |
Why?
|
Ultrasonography | 3 | 2021 | 5985 | 0.090 |
Why?
|
Angola | 1 | 2008 | 16 | 0.080 |
Why?
|
Boston | 1 | 2022 | 9313 | 0.080 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1439 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7279 | 0.080 |
Why?
|
Malaria | 1 | 2018 | 1239 | 0.080 |
Why?
|
Biomedical Technology | 1 | 2011 | 220 | 0.080 |
Why?
|
Retrospective Studies | 3 | 2022 | 77449 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 1738 | 0.080 |
Why?
|
Internship and Residency | 1 | 2008 | 5788 | 0.080 |
Why?
|
Prospective Studies | 4 | 2024 | 53288 | 0.080 |
Why?
|
Length of Stay | 1 | 2021 | 6309 | 0.080 |
Why?
|
Poverty | 2 | 2016 | 2660 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3610 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2022 | 15540 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3158 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3528 | 0.070 |
Why?
|
Renal Replacement Therapy | 1 | 2008 | 257 | 0.070 |
Why?
|
Health Personnel | 1 | 2019 | 3218 | 0.060 |
Why?
|
Physicians | 1 | 2023 | 4567 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8388 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2021 | 63114 | 0.060 |
Why?
|
Radiography | 1 | 2016 | 7023 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6895 | 0.060 |
Why?
|
Incidence | 2 | 2016 | 20947 | 0.060 |
Why?
|
Risk | 1 | 2016 | 9687 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 2019 | 5319 | 0.060 |
Why?
|
Health Care Costs | 1 | 2017 | 3209 | 0.060 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 5391 | 0.050 |
Why?
|
Forecasting | 1 | 2011 | 2951 | 0.050 |
Why?
|
Workplace | 1 | 2007 | 836 | 0.050 |
Why?
|
CD4 Lymphocyte Count | 1 | 2007 | 2559 | 0.050 |
Why?
|
HIV Infections | 1 | 2007 | 16718 | 0.050 |
Why?
|
Models, Statistical | 1 | 2016 | 5102 | 0.050 |
Why?
|
Aged | 3 | 2022 | 163280 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12788 | 0.050 |
Why?
|
Prognosis | 1 | 2021 | 29063 | 0.050 |
Why?
|
Withholding Treatment | 1 | 2023 | 599 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20129 | 0.040 |
Why?
|
Prevalence | 2 | 2021 | 15226 | 0.040 |
Why?
|
Biopsy | 1 | 2009 | 6756 | 0.040 |
Why?
|
Bangladesh | 1 | 2018 | 687 | 0.040 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 1179 | 0.030 |
Why?
|
Antigens, Fungal | 1 | 2016 | 70 | 0.030 |
Why?
|
Teaching Rounds | 1 | 2019 | 253 | 0.030 |
Why?
|
Professional-Family Relations | 1 | 2019 | 482 | 0.030 |
Why?
|
Internationality | 1 | 2020 | 1003 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2019 | 921 | 0.030 |
Why?
|
Equipment Design | 1 | 2022 | 3582 | 0.030 |
Why?
|
Cohort Studies | 1 | 2016 | 40561 | 0.030 |
Why?
|
Risk Factors | 2 | 2021 | 72290 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1076 | 0.030 |
Why?
|
Drug Resistance | 1 | 2017 | 1609 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2023 | 3843 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 56430 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2518 | 0.020 |
Why?
|
Pain | 1 | 2023 | 4986 | 0.020 |
Why?
|
Antitubercular Agents | 1 | 2016 | 1320 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2014 | 2453 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7785 | 0.020 |
Why?
|
Mental Health | 1 | 2021 | 3019 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
Parents | 1 | 2019 | 3407 | 0.020 |
Why?
|
Risk Assessment | 1 | 2021 | 23338 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 25625 | 0.010 |
Why?
|
Infant | 1 | 2017 | 35136 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 41006 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 25043 | 0.010 |
Why?
|